Literature DB >> 10903629

Heart disease and the inflammatory response.

W Koenig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903629      PMCID: PMC1118197          DOI: 10.1136/bmj.321.7255.187

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

Review 2.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

3.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

Authors:  P M Ridker; N Rifai; M Pfeffer; F Sacks; S Lepage; E Braunwald
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

4.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; J R Gallimore; M B Pepys
Journal:  BMJ       Date:  2000-07-22

5.  Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.

Authors:  N J Wald; M R Law; J K Morris; X Zhou; Y Wong; M E Ward
Journal:  BMJ       Date:  2000-07-22

6.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

7.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

8.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

Authors:  P M Ridker; N Rifai; M J Stampfer; C H Hennekens
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

9.  C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.

Authors:  P M Ridker; R J Glynn; C H Hennekens
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

10.  C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.

Authors:  M Griselli; J Herbert; W L Hutchinson; K M Taylor; M Sohail; T Krausz; M B Pepys
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  4 in total

1.  Sonographic fatty liver, overweight and ischemic heart disease.

Authors:  Yu-Cheng Lin; Huey-Ming Lo; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

2.  Abnormal liver function and central obesity associate with work-related fatigue among the Taiwanese workers.

Authors:  Yu-Cheng Lin; Jong-Dar Chen; Chao-Jen Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

3.  Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.

Authors:  Eric M Mortensen; Brandy Nakashima; John Cornell; Laurel A Copeland; Mary Jo Pugh; Antonio Anzueto; Chester Good; Marcos I Restrepo; John R Downs; Christopher R Frei; Michael J Fine
Journal:  Clin Infect Dis       Date:  2012-08-23       Impact factor: 9.079

4.  Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction.

Authors:  Limei Zhou; Asim Azfer; Jianli Niu; Sarabeth Graham; Mahua Choudhury; Frances M Adamski; Craig Younce; Phillip F Binkley; Pappachan E Kolattukudy
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.